Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Mayne Pharma Group Limited
  6. Financials
    MYX   AU000000MYX0

MAYNE PHARMA GROUP LIMITED

(MYX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: June 2019 2020 2021 2022 2023 2024
Capitalization1 807646565477--
Enterprise Value (EV)1 1 088907814736745703
P/E ratio -2,68x-6,34x-2,41x-14,0x31,1x8,41x
Yield -----1,23%
Capitalization / Revenue 1,54x1,41x1,41x1,05x0,86x0,75x
EV / Revenue 2,07x1,98x2,03x1,62x1,34x1,10x
EV / EBITDA 8,31x9,51x12,8x12,1x6,46x3,96x
Price to Book 0,80x0,62x0,73x0,60x0,59x0,55x
Nbr of stocks (in thousands) 1 582 9371 679 0681 764 8411 764 841--
Reference price (AUD) 0,510,390,320,270,270,27
Announcement Date 08/22/201908/20/202008/26/2021---
1 AUD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: June 2019 2020 2021 2022 2023 2024
Net sales1 525457401455555639
EBITDA1 13195,363,560,8115178
Operating profit (EBIT)1 37,211,7-3,70-17,841,3106
Operating Margin 7,08%2,56%-0,92%-3,92%7,44%16,7%
Pre-Tax Profit (EBT)1 -354-135-264-44,513,996,1
Net income1 -281-92,8-208-28,112,358,4
Net margin -53,5%-20,3%-52,0%-6,17%2,21%9,14%
EPS2 -0,19-0,06-0,13-0,020,010,03
Dividend per Share2 -----0,00
Announcement Date 08/22/201908/20/202008/26/2021---
1 AUD in Million
2 AUD
Previous periodNext period
Income Statement Evolution (Quarterly data)
Fiscal Period: June 2019 S1 2019 S2 2020 S1 2020 S2 2021 S1 2021 S2
Net sales1 274251227230209192
EBITDA1 81,249,747,447,939,923,6
Operating profit (EBIT)1 19,60,50-12,324,02,30-6,00
Operating Margin 7,13%0,20%-5,41%10,4%1,10%-3,13%
Pre-Tax Profit (EBT)1 11,9-366-25,0-110-229-34,6
Net income1 2,60-283-17,5-75,3-181-27,1
Net margin 0,95%-113%-7,70%-32,8%-86,8%-14,1%
EPS2 0,00-0,19-0,01--0,12-0,02
Dividend per Share ------
Announcement Date 02/21/201908/22/201902/20/202008/20/202002/23/202108/26/2021
1 AUD in Million
2 AUD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: June 2019 2020 2021 2022 2023 2024
Net Debt1 280260249260268227
Net Cash position1 ------
Leverage (Debt / EBITDA) 2,14x2,73x3,92x4,27x2,33x1,28x
Free Cash Flow1 94,743,941,811,728,088,1
ROE (Net Profit / Equities) 1,26%-1,25%-3,14%-1,45%4,17%9,93%
Shareholders' equity1 -22 2527 3976 6291 941295588
ROA (Net Profit / Asset) 0,81%-0,74%-1,73%0,20%2,93%6,40%
Assets1 -34 53012 52012 071-14 039419912
Book Value Per Share2 0,640,620,440,450,460,49
Cash Flow per Share2 0,070,060,040,020,040,07
Capex1 11,98,9917,130,735,641,4
Capex / Sales 2,27%1,97%4,26%6,74%6,41%6,47%
Announcement Date 08/22/201908/20/202008/26/2021---
1 AUD in Million
2 AUD
Previous periodNext period
Key data
Capitalization (AUD) 476 507 004
Capitalization (USD) 343 329 493
Net sales (AUD) 400 800 000
Net sales (USD) 286 419 696
Number of employees 967
Sales / Employee (AUD) 414 478
Sales / Employee (USD) 296 194
Free-Float 77,2%
Free-Float capitalization (AUD) 367 884 271
Free-Float capitalization (USD) 265 065 402
Avg. Exchange 20 sessions (AUD) 382 773
Avg. Exchange 20 sessions (USD) 273 537
Average Daily Capital Traded 0,08%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA